Cardiovascular Outcomes with GLP-1 Receptor Agonists in Patients with Diabetes or Obesity Undergoing Transcatheter Aortic Valve Replacement

By afschroeder • April 23, 2026

Goyal A, Saeed H, Jain H, Hurjkaliani S, Mahalwar G, Jaiswal V, Ricciardi MJ, Kolte D, Fonarow GC, Piazza G, Kapadia S, Qamar A. Cardiovascular Outcomes with GLP-1 Receptor Agonists in Patients with Diabetes or Obesity Undergoing Transcatheter Aortic Valve Replacement. Can J Cardiol. 2026 Apr 20:S0828-282X(26)00358-2. doi: 10.1016/j.cjca.2026.04.003. Epub ahead of print. PMID: 42019817.

Tags: Cardiology/Epi, glp-1 ra, mortality, Outcomes, Publications, Structural, TAVR, transcatheter aortic valve replacement

Waitlist mortality and post transplant survival amongst non-extracorporeal membrane oxygenation high-urgency heart transplant recipients before and after the 2018 policy change

White JP, Song J, Kim ST, Zappacosta H, Cho PD, McKay S, Girish A, Abramov A, Daniel M, Telesca D, Husain M, Ardehali A. Waitlist[...]

Evaluating the 2023 safety-net kidney policy: Eligibility and outcomes of heart transplant recipients in the United States

Zappacosta H, Daniel M, Tan N, Cho PD, Song J, White JP, Ardehali A. Evaluating the 2023 safety-net kidney policy: Eligibility and outcomes of heart[...]

Prediction of All-Cause Mortality, Cardiovascular Mortality, and Angiographic Coronary Disease From LVEF Reserve: Findings From the Multicenter REFINE PET Registry

Hijazi W, Zhou J, Miller RJH, Ramirez G, Lemley M, Shanbhag A, Kwiecinski J, Kavanagh PB, Parekh T, Liang JX, Alexanderson E, Carvajal-Juarez I, Slipczuk[...]